☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Corium
Corium Entered into Exclusive Collaboration and License Agreement with Lotus Pharmaceutical for Adlarity to Treat Alzheimer's Dise...
August 10, 2023
Insights+: The US FDA New Drug Approvals in March 2022
April 21, 2022
Corium’s Adlarity (donepezil transdermal system) Receives the US FDA’s Approval for the Treatment of Alzheimer Disease
March 14, 2022
Insights+: The US FDA New Drug Approvals in March 2021
April 15, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.